There is an error in the first sentence of the fifth paragraph in the "Methods" section. The correct sentence is: We compared baseline characteristics (at the time of first-line ART failure), rates of key adverse events, treatment discontinuation and virologic suppression among patients receiving second-line ART and concomitant tuberculosis therapy who received super-boosted lopinavir (with ritonavir 400 mg twice daily) and patients who received standard boosted lopinavir (with ritonavir 100 mg twice daily).
Citation: Murphy RA, Marconi VC, Gandhi RT, Kuritzkes DR, Sunpath H (2013) Correction: Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa. PLoS ONE 8(12): 10.1371/annotation/730cdfd0-78c5-48fc-a095-f633905ff2f0. https://doi.org/10.1371/annotation/730cdfd0-78c5-48fc-a095-f633905ff2f0
Published: December 9, 2013
Copyright: © 2013 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.